Black Market Retatrutide Is Everywhere Online: What a New JAMA Report Found
Author
Date Published
- Twitter
- Facebook
- LinkedIn
- Instagram
- Copy Link
Search for retatrutide online and you'll find dozens of sites ready to sell it, often for less than the weight loss shots your doctor can prescribe. But no country in the world has approved it yet. A JAMA news report from October 9 looked at who's selling it, what's really in the vials, and why so many people buy it anyway (JAMA). Below is what it found, in plain words, and how to keep yourself safe.
Who This Helps
This is for anyone who has seen retatrutide or other "next" weight loss drugs pushed on social media and wondered if they're worth a try. It's also for anyone curious about peptides, since the word now covers both approved drugs and plain vials sold as lab supplies.
What retatrutide and zenagamtide are
Both are real drugs in the last stage of testing, and the early results are strong, which is part of why demand is so high. Retatrutide comes from Eli Lilly, and it acts on three hormones that help steer blood sugar and hunger. In a trial of about 2,300 adults, people on the top dose lost 25% of their body weight in 80 weeks. People on a dummy shot lost about 4% (JAMA).
Zenagamtide comes from Novo Nordisk and pairs a GLP-1 with a second hormone that helps you feel full. Novo is testing it both as a daily pill and as a weekly shot (JAMA). Both drugs are still being studied, so the full safety picture isn't known yet.
Why people are buying them anyway
Cost is a big part of it. About 40% of US adults have obesity, many health plans don't cover the approved GLP-1s, and black market vials tend to cost less (JAMA). Social media adds fuel. A consumer group found that influencers with millions of followers call it better than semaglutide, the drug in Ozempic and Wegovy. Some even show people how to dose and inject it (JAMA).
Researchers who study the wider peptide trend, which covers far more than weight loss, see the same pull. In a JAMA piece this summer, a team from three countries said peptide posts of all kinds had topped 130,000 on Instagram by May 2026. On TikTok, they'd drawn 230 million views (University of Toronto). They also warned that when rules change, people may turn to riskier sellers rather than stop.
Find a provider in your state
Answer a few questions and see live pricing from the providers that ship where you live.
What's actually in the vials
Since vials sold as retatrutide aren't approved, no one checks them before they ship. The JAMA report describes several things that have gone wrong so far:
- Wrong doses. A team in Australia sent off three vials that each said 10 mg on the label. All three had the drug in them, but one had about half that much, one had about twice as much, and one had about two-thirds more (JAMA).
- The wrong drug entirely. A patient in Australia had a tear in the food pipe that could have killed them, after using a black market product sold as retatrutide. Tests found it held a high dose of semaglutide and none of the drug on the label (JAMA).
- Liver problems. Health officials in the Australian state of Victoria got reports of six cases of liver harm tied to products labeled retatrutide or its nicknames (JAMA).
- Hospital stays in the US. Public Citizen, a consumer group, counted at least 14 hospital stays among users in FDA side effect reports. The true number isn't known (JAMA).
Many sites label their vials "for research purposes only" or "not for human use," then tell you how to dose them anyway. A researcher quoted by JAMA called that label "some sort of legal cover" (JAMA). The FDA has sent 21 warning letters to sellers of the drug since December 2024. Even so, one business that got a letter in August was still featuring the drug on its homepage five weeks later.
Last month we covered a test of 18 vials sold as retatrutide, and only one matched its label (GLP Winner). The sample sizes are small in both cases, so they can't tell you how often vials are wrong across the whole market. They do show that you can't know what you're getting.
A word on peptides in general
The word "peptide" just means a short chain of amino acids. Some of the most useful drugs in the world are peptides, like semaglutide and tirzepatide. So the problem here isn't the word. The problem is buying a drug that hasn't been tested or approved, from a seller no one has checked.
The rules for some other peptides are also on the move. In July, a panel that advises the FDA said six peptides should be added to the list that licensed pharmacies can use. That vote is only advice, and nothing changes until the FDA acts on it (Frier Levitt). Retatrutide isn't one of the six, and the FDA says it can't be compounded under federal law (FDA). We explain what a legal path looks like in our guide to peptides at telehealth checkouts.
How to tell a safe source from a risky one
The FDA's BeSafeRx program lists what a safe online pharmacy does (FDA). Its warnings about unapproved weight loss drugs add a few more red flags (FDA). A safe source will:
- Require a prescription from a licensed health care worker, after a health screening.
- Have a US physical address and a license from the pharmacy board in your state.
- Have a licensed pharmacist you can reach with questions.
Be wary of prices that seem too good to be true. Be wary, too, of vials marked "for research" that come with dosing steps. The FDA says that label is false when the vial is sold to the public. A lab report on a website isn't the same as a pharmacy license, which we explain in this guide.
If you've already used a product like this, you don't need to hide it. One doctor quoted by JAMA urged patients to be honest with their care team about anything they take, even drugs bought online. That way the team can watch for problems (JAMA).
The bigger picture
The same doctor, Dr. Ivania Rizo of Boston University, said lawsuits and penalties won't get to the root of the demand for these drugs. In her view, making approved drugs cheaper and easier to get is essential if we want people to avoid risky options (JAMA). Our own reporting points the same way: the more a patient owes, the more likely a new brand-name prescription goes unfilled, across all kinds of drugs (GLP Winner). If price is what's pushing you toward a gray-market vial, check the cash-pay prices for approved options like Zepbound and for licensed compounded options first.
Final Takeaway
Retatrutide and zenagamtide look good in trials, but neither is approved anywhere, and vials sold online have turned up with the wrong dose or the wrong drug. Peptides as a group aren't the danger here, while untested products from unchecked sellers are. If you want the newest results, the safest route is a licensed pharmacy and a prescriber who knows what you're taking.
If you enjoy posts like these, you can subscribe to receive newsletter updates.
Frequently Asked Questions
Is retatrutide FDA approved?
No. As of October 2026, retatrutide hasn't been approved by the FDA or any other country's regulator. It's still in clinical trials, so anything sold online as retatrutide is unapproved.
Is it legal to buy retatrutide labeled for research?
The FDA says a "for research" label is false when the product is sold to the public with dosing instructions, and it has warned companies that sell this way. Whatever the label says, it doesn't make the product safe or tested.
What should I do if I've already used black market retatrutide?
Tell your doctor, even if it feels awkward. Watch for signs of liver trouble, such as itchy skin, dark urine or yellowing skin or eyes, which Australian health officials told users to look out for, and get care right away if they show up.
Find a provider in your state
Answer a few questions and see live pricing from the providers that ship where you live.
Keep Reading
Retatrutide shows major Phase 3 weight-loss results but remains investigational. Learn what’s real in 2026 and why social ads can be misleading.
%2520doing%2520lap%2520swimming%2520in%2520a%2520long%2520outdoor%2520pool.png&w=3840&q=100)
Retatrutide is not FDA approved. Learn why buying it online or in stores is not legal or safe, and how licensed pharmacy compounding is different.
An Australian lab tested 18 vials sold as retatrutide. One matched its label. See what the dosing errors were and why a purity test proves little.
Categories
Written by
Lauren PescarusLauren Pescarus is a team member with GLP Winner where she works on marketing, content creation, and operations. She has over 10 years experience in the content creation space, including in the GLP-1 space where she works to stay on top of access news, research updates, and lifestyle tips guided by science.